腾讯网1 个月
葛兰素史克在Zantac案件中达成22亿美元的和解协议
葛兰素史克 在美国州法院Zantac案件中达成高达22亿美元的和解协议。 葛兰素史克公司周三表示，已与10家原告公司达成协议，这些公司占美国州法院 ...
WJET Erie on MSN1 个月
Drugmaker to settle nearly 80,000 Zantac lawsuits for up to $2.2 billion
(WJET/WFXP) — UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 ...
Redlands Daily Facts1 个月
GSK to settle 80,000 Zantac cases for up to $2.2 billion
GSK Plc said it will pay as much as $2.2 billion to resolve about 80,000 US court cases related to allegations that its old reflux medication Zantac was contaminated with a suspected carcinogen.
Daily Maverick on MSN5 个月
First Zantac cancer case to go to trial ends in win for pharmaceutical companies
Jurors on Thursday found that GSK and Boehringer weren’t liable for Angela Valadez’s injuries and that the companies had properly marketed the medication without a warning about its alleged ...
pharmaphorum1 年
First Zantac cancer case dropped before trial, without settlement
The FDA banned sales of ranitidine in 2020 over possible contamination with the suspected carcinogen N-nitrosodimethylamine (NDMA. Some manufacturers of the drug voluntarily suspended sales in ...
MarketWatch1 个月
GSK settles vast majority of Zantac claims for $2.2 billion
GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...
GSK shares jump on $2.2 billion Zantac settlement
GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a $2.2 billion settlement over U.S. lawsuits that alleged its discontinued heartburn drug Zantac caused cancer.